Evidence map›Paper›PMID 40707625›Full record

ArticleThe EMBO journal2025

ALS-associated RNA-binding proteins promote UNC13A transcription through REST downregulation.

Yasuaki Watanabe, Naoki Suzuki, Tadashi Nakagawa, Masaki Hosogane, Tetsuya Akiyama, Naotoshi Kageyama, Yukino Funayama, Hitoshi Warita, Satoru Morimoto, Hideyuki Okano and 2 more

Abstract read
In one paragraph

Article in The EMBO journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. TDP-43: [GU]-ardian of the transcriptome.Molecular neurodegeneration · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yasuaki WatanabeDepartment of Neurology, Graduate School of Medicine, Tohoku University, Sendai, Miyagi, 980-8575, Japan. yasuaki.watanabe.b8@tohoku.ac.jp.ORCID http://orcid.org/0009-0006-3347-1628
Naoki SuzukiDepartment of Neurology, Graduate School of Medicine, Tohoku University, Sendai, Miyagi, 980-8575, Japan.ORCID http://orcid.org/0000-0001-8880-8554
Tadashi NakagawaDivision of Cell Proliferation, ART, Graduate School of Medicine, Tohoku University, Sendai, Miyagi, 980-8575, Japan.
Masaki HosoganeDivision of Cell Proliferation, ART, Graduate School of Medicine, Tohoku University, Sendai, Miyagi, 980-8575, Japan.ORCID http://orcid.org/0000-0001-5784-304X
Tetsuya AkiyamaDepartment of Neurology, Graduate School of Medicine, Tohoku University, Sendai, Miyagi, 980-8575, Japan.
Naotoshi KageyamaDivision of Cell Proliferation, ART, Graduate School of Medicine, Tohoku University, Sendai, Miyagi, 980-8575, Japan.
Yukino FunayamaDepartment of Neurology, Graduate School of Medicine, Tohoku University, Sendai, Miyagi, 980-8575, Japan.
Hitoshi WaritaDepartment of Neurology, Graduate School of Medicine, Tohoku University, Sendai, Miyagi, 980-8575, Japan.ORCID http://orcid.org/0000-0001-7934-3863
Satoru MorimotoKeio University Regenerative Medicine Research Center (KRM), Kawasaki, Kanagawa, 210-0821, Japan.
Hideyuki OkanoKeio University Regenerative Medicine Research Center (KRM), Kawasaki, Kanagawa, 210-0821, Japan.
Masashi AokiDepartment of Neurology, Graduate School of Medicine, Tohoku University, Sendai, Miyagi, 980-8575, Japan.
Keiko NakayamaDivision of Cell Proliferation, ART, Graduate School of Medicine, Tohoku University, Sendai, Miyagi, 980-8575, Japan. keiko.nakayama.e4@tohoku.ac.jp.ORCID http://orcid.org/0000-0003-0134-6401

Funding

Japan Agency for Medical Research and Development (AMED) JP21wm0425009Japan Agency for Medical Research and Development (AMED) JP23bm1123046Japan Agency for Medical Research and Development (AMED) JP23bm1423002Japan Agency for Medical Research and Development (AMED) JP23kk0305024Japan Agency for Medical Research and Development (AMED) JP24ek0109631MEXT | Japan Society for the Promotion of Science (JSPS) 21H02458MEXT | Japan Society for the Promotion of Science (JSPS) 21K07411MEXT | Japan Society for the Promotion of Science (JSPS) 22K15702MEXT | Japan Society for the Promotion of Science (JSPS) 23H02821MEXT | Japan Society for the Promotion of Science (JSPS) 24K02300MEXT | Japan Society for the Promotion of Science (JSPS) JP21H05278MEXT | Japan Society for the Promotion of Science (JSPS) JP22K15736
6 · The paper itself

Abstract

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by selective loss of motor neurons. Although multiple pathophysiological mechanisms have been identified, no comprehensive understanding of these heterogeneous processes has been achieved. The ALS-associated RNA-binding protein (RBP) TDP-43 has previously been shown to stabilize UNC13A mRNA by preventing cryptic exon inclusion. Here, we show that the ALS-associated RBPs MATR3, FUS, and hnRNPA1 regulate UNC13A expression by targeting the transcriptional repressor REST. These RBPs bind to and downregulate REST mRNA to promote UNC13A transcription. Loss of any of these RBPs in cultured cells or in iPSC-derived motor neurons carrying the ALS-causing FUS P525L mutation leads to REST overexpression, and the same is observed in motor neurons of individuals with familial or sporadic ALS. The functional convergence of four RBPs on the regulation of UNC13A expression underscores the important role of this process for synaptic integrity, and its association with ALS pathogenesis could be relevant for the development of new therapeutic agents.

Indexed as

Amyotrophic Lateral SclerosisNerve Tissue ProteinsRepressor ProteinsRNA-Binding Protein FUSRNA-Binding ProteinsTranscription, GeneticDNA-Binding ProteinsDown-RegulationHEK293 CellsHeterogeneous Nuclear Ribonucleoprotein A1HumansMotor NeuronsNuclear Matrix-Associated ProteinsRE1-Silencing Transcription FactorDNA-Binding ProteinsFUS protein, humanHeterogeneous Nuclear Ribonucleoprotein A1hnRNPA1 protein, humanMATR3 protein, humanNerve Tissue ProteinsNuclear Matrix-Associated ProteinsRE1-Silencing Transcription FactorRepressor ProteinsRNA-Binding Protein FUSRNA-Binding ProteinsTARDBP protein, humanALSCryptic ExonFUSRESTUNC13A

Identifiers

PMID40707625
PMCPMC12402202

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.